
Activez les alertes d’offres d’emploi par e-mail !
Générez un CV personnalisé en quelques minutes
Décrochez un entretien et gagnez plus. En savoir plus
A leading research institution in France is seeking a Postdoctoral Researcher to analyze the role of hyperglycosylated extracellular matrix in tumor growth. This position involves conducting in vitro and in vivo experiments while collaborating with other researchers and master students. Candidates should possess a PhD in life sciences, with experience in cancer biology and good command of bioinformatic tools. The role is full-time and will begin on April 1, 2026, offering a unique opportunity to work alongside top scientists in the field.
Organisation/Company CNRS Department Centre de recherche en cancérologie de Marseille Research Field Biological sciences Researcher Profile First Stage Researcher (R1) Country France Application Deadline 1 Jan 2026 - 23:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Apr 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
The postdoctoral project consists in analysing and dissecting the role of hyperglycosylated extracellular matrix (ECM) in the tumor growth and its role in promoting EMT.
The selected candidate will perform experiments in vitro and in vivo, using high-throughput microscopy, confocal microscopy, protein biochemistry and mass spectrometry. The postdoc will oversee master students, collaborate with a bioinformatics engineer and with cell biology engineer. The postdoc will be able to leverage on large glycoproteomic datasets already acquired and multiple cell lines already generated.
The postdoc will work closely with the Glynthera team, a world leader in the study of O-glycosylation role and ECM in solid tumors with a focus on pancreatic and liver cancers. The lab is dedicated to the understanding of how changes in glycosylation patterns of surface and secreted proteins drive tumor growth and survival. Glynthera is part of the CRCM, an international cancer center affiliated to CRNS, INSERM, University Aix-Marseille and the Paoli-Calmettes Cancer Institute in the South-East of France. The CRCM combines access to clinicians and patients' samples, state-of-the art technological platforms and an international pool of top scientists.
PhD in life sciences. Experience in cell and cancer biology and in vivo models of cancer. Good mastery of bioinformatic tools. Experience in multi-omic data analysis, mass spec desired. Good communication skills, good command of English, ability to work independently.